Tyrosine Kinases
Tyrosine kinase inhibitors are a broad class of compounds that inhibit tyrosine kinases, enzymes responsible for the transfer of a phosphate group to tyrosine residues on proteins, which is a critical step in cell signaling. Dysregulation of tyrosine kinases is implicated in many cancers and other diseases. These inhibitors are essential tools in the study of cell signaling pathways, cancer research, and the development of targeted therapies. At CymitQuimica, we provide a wide range of tyrosine kinase inhibitors to support your research in oncology, cell biology, and therapeutic development.
Read more
Ilginatinib hydrochloride
CAS:1239358-85-0
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2.
Formula:
C21H21ClFN7
Purity:
99.55%
Color and Shape:
Solid
Molecular weight:
425.89
Ref: TM-T12266L2
| 1mg | 93.00 € | ||
| 5mg | 222.00 € | ||
| 10mg | 311.00 € | ||
| 25mg | 455.00 € | ||
| 50mg | 655.00 € | ||
| 100mg | 940.00 € | ||
| 500mg | 1,845.00 € | ||
| 1mL*10mM (DMSO) | 209.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ilginatinib
CAS:1239358-86-1
Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2.
Formula:
C21H20FN7
Purity:
98.40% - 99.43%
Color and Shape:
Solid
Molecular weight:
389.43
Ref: TM-T12266
| 1mg | 62.00 € | ||
| 5mg | 133.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 263.00 € | ||
| 50mg | 378.00 € | ||
| 100mg | 542.00 € | ||
| 200mg | 717.00 € | ||
| 1mL*10mM (DMSO) | 128.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ilginatinib maleate
CAS:1354799-87-3
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2.
Formula:
C25H24FN7O4
Purity:
99.74%
Color and Shape:
Solid
Molecular weight:
505.5
Ref: TM-T12266L
| 1mg | 62.00 € | ||
| 5mg | 133.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 263.00 € | ||
| 50mg | 379.00 € | ||
| 100mg | 543.00 € | ||
| 200mg | 717.00 € | ||
| 1mL*10mM (DMSO) | 147.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Delgocitinib
CAS:1263774-59-9
Delgocitinib is a potent JAK inhibitor (IC50: 2.8-58 nM), treats inflammatory diseases, and is the …
Formula:
C16H18N6O
Purity:
99.90%
Color and Shape:
Solid
Molecular weight:
310.35
Ref: TM-T15096
| 1mg | 167.00 € | ||
| 5mg | 308.00 € | ||
| 10mg | 481.00 € | ||
| 25mg | 916.00 € | ||
| 50mg | 1,396.00 € | ||
| 100mg | 2,016.00 € | ||
| 200mg | 2,735.00 € | ||
| 1mL*10mM (DMSO) | 347.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
NVP-BSK805 2HCl (1092499-93-8(free base))
NVP-BSK805 2HCl (1092499-93-8(free base)) (BSK 805)(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is …
Formula:
C27H28F2N6O·2HCl
Purity:
99.13%
Color and Shape:
Solid
Molecular weight:
563.47
Ref: TM-T6294
| 1mg | 37.00 € | ||
| 5mg | 102.00 € | ||
| 10mg | 141.00 € | ||
| 25mg | 253.00 € | ||
| 50mg | 356.00 € | ||
| 100mg | 509.00 € | ||
| 200mg | 696.00 € | ||
| 1mL*10mM (DMSO) | 221.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
HNMPA-(AM)3
CAS:120944-03-8
HNMPA-(AM)3 is an insulin receptor tyrosine kinase inhibitor that inhibits metabotropic steroid production.
Formula:
C20H23O10P
Purity:
97.22%
Color and Shape:
Solid
Molecular weight:
454.36
Ref: TM-T36584
| 2mg | 183.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Cerdulatinib
CAS:1198300-79-6
Cerdulatinib (PRT2070) is an novel oral dual Syk/JAK inhibitor.
Formula:
C20H27N7O3S
Purity:
98.74% - 99.64%
Color and Shape:
Solid
Molecular weight:
445.54
Ref: TM-T2487
| 1mg | 44.00 € | ||
| 2mg | 54.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 104.00 € | ||
| 25mg | 181.00 € | ||
| 50mg | 280.00 € | ||
| 100mg | 429.00 € | ||
| 200mg | 601.00 € | ||
| 500mg | 931.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
SAR-20347
CAS:1450881-55-6
SAR-20347 is an inhibitor of TYK2, JAK1/2/3 (IC50: 0.6/23/26/41 nM).
Formula:
C21H18ClFN4O4
Purity:
99.35% - 99.77%
Color and Shape:
Solid
Molecular weight:
444.84
Ref: TM-T4210
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 113.00 € | ||
| 25mg | 221.00 € | ||
| 50mg | 344.00 € | ||
| 100mg | 573.00 € | ||
| 200mg | 808.00 € | ||
| 1mL*10mM (DMSO) | 86.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Filgotinib
CAS:1206161-97-8
Filgotinib (GLPG0634) is a selective JAK1 inhibitor. The IC50 values against JAK1, JAK2, JAK3, and …
Formula:
C21H23N5O3S
Purity:
98.03% - ≥95%
Color and Shape:
Solid
Molecular weight:
425.5
Ref: TM-T1929
| 1mg | 38.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 109.00 € | ||
| 25mg | 161.00 € | ||
| 50mg | 241.00 € | ||
| 100mg | 318.00 € | ||
| 1mL*10mM (DMSO) | 78.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Baricitinib
CAS:1187594-09-7
Baricitinib (INCB028050) is an orally JAK1 and JAK2 inhibitor. Baricitinib has anti-inflammatory and anti-tumor activity. …
Formula:
C16H17N7O2S
Purity:
100% - 99.79%
Color and Shape:
Solid
Molecular weight:
371.42
Ref: TM-T2485
| 5mg | 50.00 € | ||
| 10mg | 73.00 € | ||
| 25mg | 89.00 € | ||
| 50mg | 113.00 € | ||
| 100mg | 142.00 € | ||
| 200mg | 184.00 € | ||
| 500mg | 306.00 € | ||
| 1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Peficitinib
CAS:944118-01-8
Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.
Formula:
C18H22N4O2
Purity:
98.67% - 99.4%
Color and Shape:
Solid
Molecular weight:
326.39
Ref: TM-T6933
| 2mg | 40.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 176.00 € | ||
| 50mg | 272.00 € | ||
| 100mg | 424.00 € | ||
| 200mg | 634.00 € | ||
| 1mL*10mM (DMSO) | 73.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
CZC-8004
CAS:916603-07-1
CZC-8004 (CZC-00008004) is a pan-kinase(ABL kinase) inhibitor and binds a range of tyrosine kinases.
Formula:
C17H16FN5
Purity:
99.29%
Color and Shape:
Solid
Molecular weight:
309.34
Ref: TM-T7186
| 1mg | 47.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 143.00 € | ||
| 25mg | 294.00 € | ||
| 50mg | 439.00 € | ||
| 100mg | 632.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Deucravacitinib
CAS:1609392-27-9
Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable, allosteric TYK2 inhibitor.Cost-effective and quality-assured.
Formula:
C20H19D3N8O3
Purity:
100% - 99.43%
Color and Shape:
Solid
Molecular weight:
425.46
Ref: TM-T14687
| 1mg | 69.00 € | ||
| 5mg | 149.00 € | ||
| 10mg | 269.00 € | ||
| 25mg | 425.00 € | ||
| 50mg | 625.00 € | ||
| 100mg | 892.00 € | ||
| 200mg | 1,205.00 € | ||
| 500mg | 1,784.00 € | ||
| 1mL*10mM (DMSO) | 165.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Oclacitinib maleate
CAS:1640292-55-2
Oclacitinib maleate is a selective JAK inhibitor (IC50: 10-99 nM; JAK1 cytokines: 36-249 nM), with …
Formula:
C15H23N5O2S·C4H4O4
Purity:
99.17%
Color and Shape:
Solid
Molecular weight:
453.51
Ref: TM-T6914
| 1mg | 39.00 € | ||
| 2mg | 50.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 97.00 € | ||
| 25mg | 171.00 € | ||
| 50mg | 267.00 € | ||
| 100mg | 446.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Pyridone 6
CAS:457081-03-7
Pyridone 6, a selective JAK1/2/3 and Tyk2 inhibitor with IC50s: JAK1=15 nM, JAK2=1 nM, JAK3 …
Formula:
C18H16FN3O
Purity:
97.10% - 98.74%
Color and Shape:
Solid
Molecular weight:
309.34
Ref: TM-T3080
| 1mg | 81.00 € | ||
| 2mg | 105.00 € | ||
| 5mg | 159.00 € | ||
| 10mg | 218.00 € | ||
| 25mg | 441.00 € | ||
| 50mg | 648.00 € | ||
| 100mg | 918.00 € | ||
| 500mg | 1,838.00 € | ||
| 1mL*10mM (DMSO) | 176.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ruxolitinib (S enantiomer)
CAS:941685-37-6
Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective …
Formula:
C17H18N6
Purity:
99.5% - 99.79%
Color and Shape:
Solid
Molecular weight:
306.36
Ref: TM-T6156
| 5mg | 63.00 € | ||
| 10mg | 74.00 € | ||
| 50mg | 113.00 € | ||
| 100mg | 151.00 € | ||
| 1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
GLPG0634 analog
CAS:1206101-20-3
GLPG0634 analog (GLPG0634 analogue) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for …
Formula:
C23H18N6O2
Purity:
100% - 99.22%
Color and Shape:
Solid
Molecular weight:
410.43
Ref: TM-T3076
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 143.00 € | ||
| 25mg | 260.00 € | ||
| 50mg | 460.00 € | ||
| 100mg | 650.00 € | ||
| 500mg | 1,352.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Baricitinib phosphate
CAS:1187595-84-1
Baricitinib phosphate (INCB028050) is a selective orally bioavailable JAK1/JAK2 inhibitor.
Formula:
C16H20N7O6PS
Purity:
98.87% - 99.68%
Color and Shape:
Solid
Molecular weight:
469.41
Ref: TM-T2360
| 5mg | 47.00 € | ||
| 10mg | 62.00 € | ||
| 25mg | 91.00 € | ||
| 50mg | 113.00 € | ||
| 100mg | 142.00 € | ||
| 500mg | 343.00 € | ||
| 1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Decernotinib
CAS:944842-54-0
Decernotinib (VRT-831509)(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhibitor with Ki …
Formula:
C18H19F3N6O
Purity:
100% - 99.45%
Color and Shape:
Solid
Molecular weight:
392.38
Ref: TM-T2636
| 1mg | 52.00 € | ||
| 2mg | 68.00 € | ||
| 5mg | 93.00 € | ||
| 10mg | 130.00 € | ||
| 25mg | 257.00 € | ||
| 50mg | 456.00 € | ||
| 100mg | 639.00 € | ||
| 500mg | 1,327.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
ZAP-180013
CAS:873080-25-2
ZAP-180013 is an inhibitor of zeta-chain-associated protein kinase 70 (ZAP70,IC50 : 1.8 μM).
Formula:
C19H17Cl2N3O4S
Purity:
98.63%
Color and Shape:
Solid
Molecular weight:
454.33
Ref: TM-T8697
| 5mg | 69.00 € | ||
| 10mg | 95.00 € | ||
| 25mg | 182.00 € | ||
| 50mg | 346.00 € | ||
| 100mg | 554.00 € | ||
| 1mL*10mM (DMSO) | 77.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
